V., Pecoits-Filho, R., Guedes, M., Arnott, C., et al
#WeFindAWay #HERology #WomensHealth #GLP1 | The Mount Sinai Hospital
Older adults with risk factors for dementia who are also metabolically eligible for GLP-1 therapy meaning those with obesity, type 2 diabetes, or related metabolic conditions may represent the most relevant candidate population based on the existing evidence
What Makes Josie Stand Out Its built specifically for women 35+ in perimenopause or menopause It offers both GLP-1 medications and hormone replacement therapy (HRT) It includes compounded semaglutide and tirzepatide options (both injections and oral options) It provides GLP-1 microdosing options It offers flexible treatment plans (monthly, 3-month, 6-month, 12-month options) for reduced monthly costs Where most providers are focusing on weight loss only, Josie is serving the whole picture, offering full metabolic and hormonal health care options
Are There Differences in Medical Weight Loss Options
